2021 Vitiligo International Symposium – David Rosmarin, MD

Invited Speaker

Title

Efficacy and Safety of Ruxolitinib Cream for the Treatment of Vitiligo: 24-Week Results From 2 Randomized, Double-Blind Phase 3 Studies